3
Announcements
Trials
Browse
Landscape
Status
Enrolling by invitation
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Genitourinary
1
Dermatologic
1
Breast
1
Conditions
Uterine Cervical Neoplasms
31
Prostatic Neoplasms
17
Breast Neoplasms
8
Sarcoma
6
Vaginal Neoplasms
4
Neoplasms
4
Endometrial Neoplasms
4
Vulvar Neoplasms
3
Uterine Neoplasms
3
Lung Neoplasms
3
Carcinoma, Ductal, Breast
3
Radiation Injuries
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Gliosarcoma
2
Glioblastoma
2
Esophageal Neoplasms
2
Desmoplastic Small Round Cell Tumor
2
Central Nervous System Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Intraductal, Noninfiltrating
2
Carcinoma, Hepatocellular
2
Breast Carcinoma In Situ
2
Anemia
2
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Retinoblastoma
1
Recurrent Head and Neck Carcinoma
1
Rectal Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Neoplasms
1
Interventions
Ipilimumab
114
pembrolizumab
95
Nivolumab
91
aldesleukin
86
Interleukin-2
57
Cyclophosphamide
54
Dacarbazine
52
Vemurafenib
39
trametinib
37
Temozolomide
37
incomplete Freund's adjuvant
35
fludarabine phosphate
35
sargramostim
32
dabrafenib
32
fludarabine
26
Bevacizumab
26
Paclitaxel
22
MART-1 Antigen
21
Granulocyte-Macrophage Colony-Stimulating Factor
21
montanide ISA 51
20
Interferon-alpha
20
Cisplatin
20
Carboplatin
19
Sorafenib
18
Introns
17
Biopsy
17
cobimetinib
16
Radiosurgery
16
atezolizumab
15
Radiotherapy
15
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Melanoma
×
Brachytherapy
×
Clear all
NCT01777802
2025-08-27
SBRT
Mayo Clinic
Completed
98 enrolled